Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.

Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, Klein H, Steiner J, Frodl T, Bogerts B, Tian L, Groc L, Hasan A, Baune BT, Endres D, Haroon E, Yolken R, Benedetti F, Halaris A, Meyer JH, Stassen H, Leboyer M, Fuchs D, Otto M, Brown DA, Vincent A, Najjar S, Bechter K.

Lancet Psychiatry. 2019 Oct 24. pii: S2215-0366(19)30290-1. doi: 10.1016/S2215-0366(19)30290-1. [Epub ahead of print] Review. Erratum in: Lancet Psychiatry. 2019 Nov 4;:.

PMID:
31669058
2.

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics.

Gréa H, Bouchet D, Rogemond V, Hamdani N, Le Guen E, Tamouza R, Darrau E, Passerieux C, Honnorat J, Leboyer M, Groc L.

Front Psychiatry. 2019 Sep 13;10:670. doi: 10.3389/fpsyt.2019.00670. eCollection 2019.

3.

Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune Disease.

Ciappelloni S, Bouchet D, Dubourdieu N, Boué-Grabot E, Kellermayer B, Manso C, Marignier R, Oliet SHR, Tourdias T, Groc L.

Cell Rep. 2019 Jun 25;27(13):3860-3872.e4. doi: 10.1016/j.celrep.2019.05.097.

4.

Surface trafficking of neurotransmitter receptors: From cultured neurons to intact brain preparations.

Dupuis JP, Groc L.

Neuropharmacology. 2019 May 17:107642. doi: 10.1016/j.neuropharm.2019.05.019. [Epub ahead of print] Review.

PMID:
31108111
5.

Role of CX3CR1 Signaling on the Maturation of GABAergic Transmission and Neuronal Network Activity in the Neonate Hippocampus.

Bertot C, Groc L, Avignone E.

Neuroscience. 2019 May 15;406:186-201. doi: 10.1016/j.neuroscience.2019.03.006. Epub 2019 Mar 12.

PMID:
30872165
6.

Nanoscale exploration of the extracellular space in the live brain by combining single carbon nanotube tracking and super-resolution imaging analysis.

Paviolo C, Soria FN, Ferreira JS, Lee A, Groc L, Bezard E, Cognet L.

Methods. 2019 Mar 9. pii: S1046-2023(18)30451-1. doi: 10.1016/j.ymeth.2019.03.005. [Epub ahead of print]

PMID:
30862507
7.

Differential Nanoscale Topography and Functional Role of GluN2-NMDA Receptor Subtypes at Glutamatergic Synapses.

Kellermayer B, Ferreira JS, Dupuis J, Levet F, Grillo-Bosch D, Bard L, Linarès-Loyez J, Bouchet D, Choquet D, Rusakov DA, Bon P, Sibarita JB, Cognet L, Sainlos M, Carvalho AL, Groc L.

Neuron. 2018 Oct 10;100(1):106-119.e7. doi: 10.1016/j.neuron.2018.09.012. Epub 2018 Sep 27.

8.

Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis.

Jézéquel J, Johansson EM, Leboyer M, Groc L.

Trends Neurosci. 2018 Aug;41(8):502-511. doi: 10.1016/j.tins.2018.05.002. Epub 2018 May 26.

PMID:
29807730
9.

Antidepressive effects of targeting ELK-1 signal transduction.

Apazoglou K, Farley S, Gorgievski V, Belzeaux R, Lopez JP, Grenier J, Ibrahim EC, El Khoury MA, Tse YC, Mongredien R, Barbé A, de Macedo CEA, Jaworski W, Bochereau A, Orrico A, Isingrini E, Guinaudie C, Mikasova L, Louis F, Gautron S, Groc L, Massaad C, Yildirim F, Vialou V, Dumas S, Marti F, Mechawar N, Morice E, Wong TP, Caboche J, Turecki G, Giros B, Tzavara ET.

Nat Med. 2018 May;24(5):591-597. doi: 10.1038/s41591-018-0011-0. Epub 2018 May 7.

PMID:
29736027
10.

Tracking single membrane targets of human autoantibodies using single nanoparticle imaging.

Jézéquel J, Dupuis JP, Maingret F, Groc L.

J Neurosci Methods. 2018 Jul 1;304:76-82. doi: 10.1016/j.jneumeth.2018.04.012. Epub 2018 Apr 21.

PMID:
29684464
11.

Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.

Jézéquel J, Lepleux M, Kahn RS, Honnorat J, Leboyer M, Groc L.

Am J Psychiatry. 2018 Apr 1;175(4):382-383. doi: 10.1176/appi.ajp.2017.17091053. No abstract available.

PMID:
29606071
12.

Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.

Jézéquel J, Johansson EM, Dupuis JP, Rogemond V, Gréa H, Kellermayer B, Hamdani N, Le Guen E, Rabu C, Lepleux M, Spatola M, Mathias E, Bouchet D, Ramsey AJ, Yolken RH, Tamouza R, Dalmau J, Honnorat J, Leboyer M, Groc L.

Nat Commun. 2017 Nov 27;8(1):1791. doi: 10.1038/s41467-017-01700-3.

13.

Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.

Aloisi E, Le Corf K, Dupuis J, Zhang P, Ginger M, Labrousse V, Spatuzza M, Georg Haberl M, Costa L, Shigemoto R, Tappe-Theodor A, Drago F, Vincenzo Piazza P, Mulle C, Groc L, Ciranna L, Catania MV, Frick A.

Nat Commun. 2017 Oct 24;8(1):1103. doi: 10.1038/s41467-017-01191-2.

14.

Dynamics of surface neurotransmitter receptors and transporters in glial cells: Single molecule insights.

Ciappelloni S, Murphy-Royal C, Dupuis JP, Oliet SHR, Groc L.

Cell Calcium. 2017 Nov;67:46-52. doi: 10.1016/j.ceca.2017.08.009. Epub 2017 Aug 25. Review.

PMID:
29029790
15.

Hyaluronic acid based extracellular matrix regulates surface expression of GluN2B containing NMDA receptors.

Schweitzer B, Singh J, Fejtova A, Groc L, Heine M, Frischknecht R.

Sci Rep. 2017 Sep 8;7(1):10991. doi: 10.1038/s41598-017-07003-3.

16.

In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease.

Chansel-Debordeaux L, Bourdenx M, Dovero S, Grouthier V, Dutheil N, Espana A, Groc L, Jimenez C, Bezard E, Dehay B.

Gene Ther. 2017 Dec;24(12):801-809. doi: 10.1038/gt.2017.84. Epub 2017 Nov 16.

PMID:
28853717
17.

Stress hormone rapidly tunes synaptic NMDA receptor through membrane dynamics and mineralocorticoid signalling.

Mikasova L, Xiong H, Kerkhofs A, Bouchet D, Krugers HJ, Groc L.

Sci Rep. 2017 Aug 14;7(1):8053. doi: 10.1038/s41598-017-08695-3.

18.

Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project.

Jézéquel J, Rogemond V, Pollak T, Lepleux M, Jacobson L, Gréa H, Iyegbe C, Kahn R, McGuire P, Vincent A, Honnorat J, Leboyer M, Groc L.

Biol Psychiatry. 2017 Nov 15;82(10):766-772. doi: 10.1016/j.biopsych.2017.06.015. Epub 2017 Jul 6.

PMID:
28780967
19.

Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017.

Kremer D, Glanzman R, Traboulsee A, Nath A, Groc L, Horwitz M, Göttle P, Perron H, Gold J, Hartung HP, Küry P.

Mult Scler Relat Disord. 2017 Jul;15:18-23. doi: 10.1016/j.msard.2017.05.001. Epub 2017 May 1.

PMID:
28641767
20.

Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses.

Ferreira JS, Papouin T, Ladépêche L, Yao A, Langlais VC, Bouchet D, Dulong J, Mothet JP, Sacchi S, Pollegioni L, Paoletti P, Oliet SHR, Groc L.

Elife. 2017 Jun 9;6. pii: e25492. doi: 10.7554/eLife.25492.

21.

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody.

Gréa H, Scheid I, Gaman A, Rogemond V, Gillet S, Honnorat J, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Delorme R, Groc L, Leboyer M.

Dialogues Clin Neurosci. 2017 Mar;19(1):65-70.

22.

[Implication of human endogenous retroviruses in schizophrenia and bipolar disorder].

Ellul P, Groc L, Leboyer M.

Med Sci (Paris). 2017 Apr;33(4):404-409. doi: 10.1051/medsci/20173304010. Epub 2017 May 12. Review. French.

23.

The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies.

Ellul P, Groc L, Tamouza R, Leboyer M.

Front Psychiatry. 2017 Apr 19;8:54. doi: 10.3389/fpsyt.2017.00054. eCollection 2017. No abstract available.

24.

Astroglial glutamate transporters in the brain: Regulating neurotransmitter homeostasis and synaptic transmission.

Murphy-Royal C, Dupuis J, Groc L, Oliet SHR.

J Neurosci Res. 2017 Nov;95(11):2140-2151. doi: 10.1002/jnr.24029. Epub 2017 Feb 2. Review.

PMID:
28150867
25.

Single-nanotube tracking reveals the nanoscale organization of the extracellular space in the live brain.

Godin AG, Varela JA, Gao Z, Danné N, Dupuis JP, Lounis B, Groc L, Cognet L.

Nat Nanotechnol. 2017 Mar;12(3):238-243. doi: 10.1038/nnano.2016.248. Epub 2016 Nov 21.

PMID:
27870840
26.

Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors.

De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, Watrin C, Benetollo C, Pernet-Gallay K, Luhmann HJ, Honnorat J, Malleret G, Groc L, Acker-Palmer A, Salin PA, Meissirel C.

Mol Psychiatry. 2016 Dec;21(12):1647. doi: 10.1038/mp.2016.215. No abstract available.

PMID:
27847390
27.

Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.

Lesept F, Chevilley A, Jezequel J, Ladépêche L, Macrez R, Aimable M, Lenoir S, Bertrand T, Rubrecht L, Galea P, Lebouvier L, Petersen KU, Hommet Y, Maubert E, Ali C, Groc L, Vivien D.

Cell Death Dis. 2016 Nov 10;7(11):e2466. doi: 10.1038/cddis.2016.279.

28.

Immuno-psychiatry: an agenda for clinical practice and innovative research.

Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L.

BMC Med. 2016 Oct 28;14(1):173.

29.

Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care.

Ellul P, Boyer L, Groc L, Leboyer M, Fond G.

Acta Psychiatr Scand. 2016 Dec;134(6):469-484. doi: 10.1111/acps.12656. Epub 2016 Oct 15. Review.

PMID:
27744648
30.

Neuroleptic intolerance in patients with anti-NMDAR encephalitis.

Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, Psimaras D, Antoine JC, Delattre JY, Groc L, Leboyer M, Honnorat J.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e280. doi: 10.1212/NXI.0000000000000280. eCollection 2016 Oct.

31.

Single nanoparticle tracking of [Formula: see text]-methyl-d-aspartate receptors in cultured and intact brain tissue.

Varela JA, Ferreira JS, Dupuis JP, Durand P, Bouchet D, Groc L.

Neurophotonics. 2016 Oct;3(4):041808. doi: 10.1117/1.NPh.3.4.041808. Epub 2016 Jul 12.

32.

Is it time for immunopsychiatry in psychotic disorders?

Leboyer M, Oliveira J, Tamouza R, Groc L.

Psychopharmacology (Berl). 2016 May;233(9):1651-60. doi: 10.1007/s00213-016-4266-1. Epub 2016 Mar 18. Review.

PMID:
26988846
33.

Targeting neurotransmitter receptors with nanoparticles in vivo allows single-molecule tracking in acute brain slices.

Varela JA, Dupuis JP, Etchepare L, Espana A, Cognet L, Groc L.

Nat Commun. 2016 Mar 14;7:10947. doi: 10.1038/ncomms10947.

34.

Hippocampal Fast Glutamatergic Transmission Is Transiently Regulated by Corticosterone Pulsatility.

Sarabdjitsingh RA, Pasricha N, Smeets JA, Kerkhofs A, Mikasova L, Karst H, Groc L, Joëls M.

PLoS One. 2016 Jan 7;11(1):e0145858. doi: 10.1371/journal.pone.0145858. eCollection 2016.

35.

A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior.

De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, Watrin C, Benetollo C, Pernet-Gallay K, Luhmann HJ, Honnorat J, Malleret G, Groc L, Acker-Palmer A, Salin PA, Meissirel C.

Mol Psychiatry. 2016 Dec;21(12):1768-1780. doi: 10.1038/mp.2015.195. Epub 2016 Jan 5.

36.

Toward the suppression of cellular toxicity from single-walled carbon nanotubes.

Gao Z, Varela JA, Groc L, Lounis B, Cognet L.

Biomater Sci. 2016 Feb;4(2):230-44. doi: 10.1039/c5bm00134j. Review.

PMID:
26678092
37.

First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015.

Nath A, Küry P, Sciascia do Olival G, Dolei A, Karlsson H, Groc L, Schneider M, Kriesel J, Touraine JL, Mallet F, Marche PN, Arnaud F, Feschotte C, Perron H.

Mob DNA. 2015 Oct 15;6:20. doi: 10.1186/s13100-015-0051-7. eCollection 2015.

38.

Temporal Memory and Its Enhancement by Estradiol Requires Surface Dynamics of Hippocampal CA1 N-Methyl-D-Aspartate Receptors.

Potier M, Georges F, Brayda-Bruno L, Ladépêche L, Lamothe V, Al Abed AS, Groc L, Marighetto A.

Biol Psychiatry. 2016 May 1;79(9):735-745. doi: 10.1016/j.biopsych.2015.07.017. Epub 2015 Jul 31.

PMID:
26321020
39.

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bézard E.

Prog Neurobiol. 2015 Sep;132:96-168. doi: 10.1016/j.pneurobio.2015.07.002. Epub 2015 Jul 21. Review.

PMID:
26209473
40.

[Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia].

Le Guen E, Doukhan R, Hamdani N, Tamouza R, Groc L, Honnorat J, Leboyer M.

Med Sci (Paris). 2015 Jan;31(1):60-7. doi: 10.1051/medsci/20153101014. Epub 2015 Feb 6. Review. French.

41.

Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission.

Murphy-Royal C, Dupuis JP, Varela JA, Panatier A, Pinson B, Baufreton J, Groc L, Oliet SH.

Nat Neurosci. 2015 Feb;18(2):219-26. doi: 10.1038/nn.3901. Epub 2015 Jan 12.

PMID:
25581361
42.

Ultradian corticosterone pulses balance glutamatergic transmission and synaptic plasticity.

Sarabdjitsingh RA, Jezequel J, Pasricha N, Mikasova L, Kerkhofs A, Karst H, Groc L, Joëls M.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14265-70. doi: 10.1073/pnas.1411216111. Epub 2014 Sep 15.

43.

Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses.

Dupuis JP, Ladépêche L, Seth H, Bard L, Varela J, Mikasova L, Bouchet D, Rogemond V, Honnorat J, Hanse E, Groc L.

EMBO J. 2014 Apr 16;33(8):842-61. doi: 10.1002/embj.201386356. Epub 2014 Mar 3.

44.

"Hyper-bright" near-infrared emitting fluorescent organic nanoparticles for single particle tracking.

Genin E, Gao Z, Varela JA, Daniel J, Bsaibess T, Gosse I, Groc L, Cognet L, Blanchard-Desce M.

Adv Mater. 2014 Apr 9;26(14):2258-61, 2257. doi: 10.1002/adma.201304602. Epub 2014 Feb 3. No abstract available.

PMID:
24497445
45.

Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis.

Glangetas C, Girard D, Groc L, Marsicano G, Chaouloff F, Georges F.

J Neurosci. 2013 Dec 11;33(50):19657-63. doi: 10.1523/JNEUROSCI.3175-13.2013.

46.

Surface trafficking of NMDA receptors: gathering from a partner to another.

Ladépêche L, Dupuis JP, Groc L.

Semin Cell Dev Biol. 2014 Mar;27:3-13. doi: 10.1016/j.semcdb.2013.10.005. Epub 2013 Oct 29. Review.

PMID:
24177014
47.

Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors.

Ladepeche L, Dupuis JP, Bouchet D, Doudnikoff E, Yang L, Campagne Y, Bézard E, Hosy E, Groc L.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):18005-10. doi: 10.1073/pnas.1310145110. Epub 2013 Oct 14.

48.

Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses.

Ladepeche L, Yang L, Bouchet D, Groc L.

PLoS One. 2013 Sep 6;8(9):e74512. doi: 10.1371/journal.pone.0074512. eCollection 2013.

49.

Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance.

Dubreucq S, Durand A, Matias I, Bénard G, Richard E, Soria-Gomez E, Glangetas C, Groc L, Wadleigh A, Massa F, Bartsch D, Marsicano G, Georges F, Chaouloff F.

Biol Psychiatry. 2013 May 1;73(9):895-903. doi: 10.1016/j.biopsych.2012.10.025. Epub 2012 Dec 11.

PMID:
23237313
50.

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking.

Porras G, Berthet A, Dehay B, Li Q, Ladepeche L, Normand E, Dovero S, Martinez A, Doudnikoff E, Martin-Négrier ML, Chuan Q, Bloch B, Choquet D, Boué-Grabot E, Groc L, Bezard E.

J Clin Invest. 2012 Nov;122(11):3977-89. doi: 10.1172/JCI59426. Epub 2012 Oct 8.

Supplemental Content

Support Center